OSMR and ovarian cancer: Based on the data from the same study11, indicating that the anti-OSMR antibody clone named B21 clone was effective in inhibiting proliferation and inducing apoptosis of ovarian cancer cells both in vitro and in vivo, we sought to test the effect of this mAb clone on cisplatin sensitivity in both the sensitive and cisplatin-resistant ovarian cancer cells.